Get the Stockscreener App
1.61
5.29%
-0.09
InspireMD Inc. stock is traded at $1.61, with a volume of 98,443.
It is down -5.29% in the last 24 hours and down -1.77% over the past month.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
See More
Previous Close:
$1.70
Open:
$1.65
24h Volume:
98,443
Relative Volume:
2.40
Market Cap:
$68.22M
Revenue:
$6.21M
Net Income/Loss:
$-19.92M
P/E Ratio:
-1.5333
EPS:
-1.05
Net Cash Flow:
$-16.76M
1W Performance:
-11.54%
1M Performance:
-1.77%
6M Performance:
-34.02%
1Y Performance:
-45.97%
1-Day Range:
$1.60
$1.8499
1-Week Range:
$1.60
$1.8526
52-Week Range:
$1.51
$3.34
InspireMD Inc. Stock (NSPR) Company Profile
Name
InspireMD Inc.
Sector
Industry
Phone
972 3 6917691
Address
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
1.61 | 72.03M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-02-26 | Initiated | Maxim Group | Buy |
| Jan-07-16 | Initiated | Rodman & Renshaw | Buy |
| Mar-13-15 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-26-13 | Initiated | Oppenheimer | Outperform |
InspireMD Inc. Stock (NSPR) Latest News
InspireMD Announces Planned Departure of Chief Operating Officer - TipRanks
InspireMD announces dismissal of chief operating officer Andrea Tommasoli By Investing.com - Investing.com Canada
InspireMD announces dismissal of chief operating officer Andrea Tommasoli - Investing.com
Embolic Protection Devices Market to Reach USD 1,161.31 Million by 2032, Growing at a CAGR of 7.58% | DelveInsight - Barchart.com
InspireMD (NSPR) outlines COO dismissal, French-law notice and €61k severance - Stock Titan
Tangible book value per share of InspireMD Inc. – LSX:A3CMP3 - TradingView
NSPR Technical Analysis & ETF Price Forecast - Intellectia AI
Can InspireMD Inc. outperform in the next rallyJuly 2025 Market Mood & AI Powered Buy and Sell Recommendations - mfd.ru
NSPR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Stock Report: Why is InspireMD Inc stock going upEarnings Growth Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
InspireMD (NSPR) Price Target Increased by 25.00% to 5.10 - Nasdaq
Lake Street reiterates InspireMD stock rating citing market growth By Investing.com - Investing.com Canada
Director adds 2,710 InspireMD (NSPR) shares in amended Form 4 - Stock Titan
What hedge fund activity signals for InspireMD Inc. stock2025 Growth vs Value & Detailed Earnings Play Strategies - mfd.ru
Aberdeen Group plc Makes New Investment in InspireMD, Inc. $NSPR - Defense World
Can InspireMD Inc. ride the EV wavePortfolio Growth Summary & Free AI Powered Buy and Sell Recommendations - mfd.ru
Is InspireMD Inc. stock a top momentum playJuly 2025 Highlights & Weekly Breakout Stock Alerts - mfd.ru
How InspireMD Inc. stock performs in interest rate cyclesEarnings Growth Summary & Weekly High Return Stock Opportunities - mfd.ru
OrbiMed discloses sizable passive stake in InspireMD (NSPR) common stock - Stock Titan
NSPR PE Ratio & Valuation, Is NSPR Overvalued - Intellectia AI
What is InspireMD Inc. s debt to equity ratioJuly 2025 Trends & Accurate Intraday Trading Signals - mfd.ru
Is InspireMD Inc. stock a contrarian buyJuly 2025 Decliners & Community Consensus Trade Signals - mfd.ru
Will InspireMD Inc. stock see PE expansionJuly 2025 Setups & Community Verified Swing Trade Signals - mfd.ru
Will InspireMD Inc. stock hit new highs in YEAR2025 Stock Rankings & Daily Profit Focused Stock Screening - mfd.ru
Rosalind funds disclose 9.2% InspireMD (NSPR) stake with warrant blocker - Stock Titan
Aberdeen Group plc Expands Stake in InspireMD Inc with Strategic Acquisition - GuruFocus
Gains Report: Why is InspireMD Inc stock going upMarket Trend Summary & Daily Price Action Insights - baoquankhu1.vn
This Insider Has Just Sold Shares In InspireMD - simplywall.st
InspireMD CCO Gleason sells $99k in NSPR stock By Investing.com - Investing.com South Africa
InspireMD (NYSE:NSPR) Now Covered by Maxim Group - Defense World
InspireMD (NYSE:NSPR) Insider Shane Thomas Gleason Sells 8,411 Shares - MarketBeat
Shane Thomas Gleason Sells 17,593 Shares of InspireMD (NYSE:NSPR) Stock - MarketBeat
Shane Thomas Gleason Sells 12,395 Shares of InspireMD (NYSE:NSPR) Stock - MarketBeat
InspireMD CCO Gleason sells $99k in NSPR stock - Investing.com
Aug Spikes: Why is InspireMD Inc stock going upJuly 2025 Breakouts & High Accuracy Trade Alerts - baoquankhu1.vn
Rate Cut: Is InspireMD Inc part of any ETFJuly 2025 Movers & Precise Entry and Exit Recommendations - baoquankhu1.vn
Jobs Data: Why is InspireMD Inc stock going upBear Alert & Weekly Momentum Stock Picks - baoquankhu1.vn
InspireMD (NYSE:NSPR) versus Motus GI (NASDAQ:MOTS) Critical Contrast - Defense World
InspireMD (NYSE:NSPR) Stock Price Down 1.8%Should You Sell? - MarketBeat
One new InspireMD hire gets 36,118-share inducement grant - Stock Titan
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.
InspireMD Approves Inducement Grants of 36,118 Shares to New Employee - Intellectia AI
Performance Recap: Is M tron Industries Inc stock a good dividend stockDividend Hike & Fast Gain Stock Trading Tips - baoquankhu1.vn
Wall Street Recap: Can InspireMD Inc keep up with sector leadersVolume Spike & Consistent Return Strategy Ideas - baoquankhu1.vn
Buyback Watch: Is InspireMD Inc stock risky to hold nowQuarterly Portfolio Summary & High Accuracy Swing Trade Signals - baoquankhu1.vn
Options Flow: Can InspireMD Inc be recession proofJuly 2025 Intraday Action & Fast Moving Stock Watchlists - baoquankhu1.vn
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC) - The Manila Times
InspireMD's CGuard® Prime Carotid Stent System Achieves Landmark Safety and Efficacy Results in C-GUARDIANS Trial Published in JACC - Quiver Quantitative
New carotid stent study reports low stroke rates for high-risk patients - Stock Titan
Chipmakers Recap: Can InspireMD Inc outperform in the next rally2025 Growth vs Value & Daily Chart Pattern Signals - baoquankhu1.vn
InspireMD Inc. Stock (NSPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):